Upon interrogating zotatifin target abundance in different breast cancer subtypes, we found that the protein level of EIF4A1 is higher in TNBC as compared with non-TNBC (Supplemental Figure 5C). The gene discussed is EIF4A1; the disease is breast carcinoma.